Metformin-induced AMPK activation promotes cisplatin resistance through PINK1/Parkin dependent mitophagy in gastric cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin-induced AMPK activation promotes cisplatin resistance through PINK1/Parkin dependent mitophagy in gastric cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-10-25
DOI
10.3389/fonc.2022.956190
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ATAD3B is a mitophagy receptor mediating clearance of oxidative stress‐induced damaged mitochondrial DNA
- (2021) Li Shu et al. EMBO JOURNAL
- Mitophagy protein PINK1 suppresses colon tumor growth by metabolic reprogramming via p53 activation and reducing acetyl-CoA production
- (2021) Kunlun Yin et al. CELL DEATH AND DIFFERENTIATION
- AMPK/ULK1-mediated phosphorylation of Parkin ACT domain mediates an early step in mitophagy
- (2021) Chien-Min Hung et al. Science Advances
- AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice
- (2021) Ya-chun Han et al. Cell Death & Disease
- The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis
- (2020) Y. Shuai et al. Clinical & Translational Oncology
- Autophagy and autophagy-related proteins in cancer
- (2020) Xiaohua Li et al. Molecular Cancer
- A Cohort Study of Antihyperglycemic Medication Exposure and Gastric Cancer Risk
- (2020) Audrius Dulskas et al. Journal of Clinical Medicine
- The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective
- (2020) Loranne Agius et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin Induces Autophagy via the AMPK-mTOR Signaling Pathway in Human Hepatocellular Carcinoma Cells
- (2020) Chun Gao et al. Cancer Management and Research
- Gastric cancer
- (2020) Elizabeth C Smyth et al. LANCET
- Chaetomugilin J Enhances Apoptosis in Human Ovarian Cancer A2780 Cells Induced by Cisplatin Through Inhibiting Pink1/Parkin Mediated Mitophagy
- (2020) Xiaoqing Hu et al. OncoTargets and Therapy
- Mitophagy promotes sorafenib resistance through hypoxia-inducible ATAD3A dependent Axis
- (2020) Hong Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inhibition of PINK1/Parkin-dependent mitophagy sensitizes multidrug-resistant cancer cells to B5G1, a new betulinic acid analog
- (2019) Nan Yao et al. Cell Death & Disease
- Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells
- (2019) Sabino Russi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PINK1 depletion sensitizes non-small cell lung cancer to glycolytic inhibitor 3-bromopyruvate: involvement of ROS and mitophagy
- (2019) Katherine Dai et al. Pharmacological Reports
- Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis
- (2018) Paul K. Ziegler et al. CELL
- Metformin inhibits TGF-β1-induced epithelial-to-mesenchymal transition-like process and stem-like properties in GBM via AKT/mTOR/ZEB1 pathway
- (2018) Yang Song et al. Oncotarget
- Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response
- (2018) Felipe V. Pereira et al. Oncotarget
- PINK1/Parkin-Mediated Mitophagy Promotes Resistance to Sonodynamic Therapy
- (2018) Lin Song et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC
- (2018) Massimo Moro et al. Journal of Thoracic Oncology
- Protective effects of metformin against osteoarthritis through upregulation of SIRT3-mediated PINK1/Parkin-dependent mitophagy in primary chondrocytes
- (2018) Chenzhong Wang et al. BioScience Trends
- Metformin attenuates hypoxia‑induced resistance to cisplatin in the HepG2 cell line
- (2018) Hiromasa Fujita et al. Oncology Letters
- Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway
- (2017) Hao Dong et al. Oncology Letters
- Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production
- (2017) Angela Mogavero et al. Scientific Reports
- Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy
- (2016) Ming Chen et al. Autophagy
- Mitochondrial Dynamics and Metabolic Regulation
- (2016) Timothy Wai et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- PINK1/Parkin-mediated mitophagy in mammalian cells
- (2015) Akinori Eiyama et al. CURRENT OPINION IN CELL BIOLOGY
- The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1/hypoxia-inducible factor-1α signaling pathway in ELT-3 cells
- (2015) Mari Tadakawa et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones)
- (2014) Leonard Howard Damelin et al. BMC CANCER
- Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt
- (2010) Kristina Janjetovic et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search